Results 121 to 130 of about 9,090,000 (291)

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance

open access: yesThe Prostate, Volume 85, Issue 12, Page 1104-1113, September 2025.
ABSTRACT Background An accurate estimation of progression risk in patients with prostate cancer (PCa) amenable to active surveillance (AS) is still an unmet need. Among available biomarkers, we considered Prolaris cell‐cycle progression (CCP) test, “triple hit” phenotype (ERG overexpression, PTEN and prostein expression loss) and elevated expression ...
Marco Oderda   +14 more
wiley   +1 more source

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment [PDF]

open access: gold, 2018
Francesca Valentino   +9 more
openalex   +1 more source

Dual-Energy CT Applications in Urological Diseases [PDF]

open access: gold, 2023
Michaela Cellina   +9 more
openalex   +1 more source

Hyperuricemia and Urologic Disease

open access: yesUrogenital Tract Infection, 2017
In-Chang Cho, Seung Ki Min
openaire   +2 more sources

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Despite advances in radiotherapy planning, some long‐term prostate cancer survivors experience persistent symptoms. Although overall quality of life appears comparable between patients treated with definitive and salvage radiotherapy and aligns with normative data, prostate‐specific deficits—particularly bowel symptoms—may persist ...
Isabella Gruber   +2 more
wiley   +1 more source

Understanding urologic scientific publication patterns and general public interests on stone disease: lessons learned from big data platforms [PDF]

open access: bronze, 2020
Giovanni Scala Marchini   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy